2020
Endoscopic Ultrasound-Guided, Percutaneous, and Transjugular Liver Biopsy: A Comparative Systematic Review and Meta-Analysis
McCarty TR, Bazarbashi AN, Njei B, Ryou M, Aslanian HR, Muniraj T. Endoscopic Ultrasound-Guided, Percutaneous, and Transjugular Liver Biopsy: A Comparative Systematic Review and Meta-Analysis. Clinical Endoscopy 2020, 53: 583-593. PMID: 33027584, PMCID: PMC7548145, DOI: 10.5946/ce.2019.211.Peer-Reviewed Original ResearchEndoscopic ultrasound-guided liver biopsyTransjugular liver biopsyPercutaneous liver biopsyLiver biopsyAdverse eventsBiopsy specimensUltrasound-guided liver biopsyCurrent clinical practiceComparative systematic reviewLonger TSLMOOSE guidelinesSubgroup analysisBACKGROUND/Endoscopic ultrasoundBiopsy adequacyInvasive proceduresClinical practiceBiopsy approachBiopsyHepatic tissueMeta-AnalysisSystematic reviewAdequacy rateBiopsy needleMajor outcomes
2015
Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Rustagi T, Njei B. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas 2015, 44: 859-867. PMID: 26168316, PMCID: PMC4824288, DOI: 10.1097/mpa.0000000000000326.Peer-Reviewed Original ResearchConceptsPost-endoscopic retrograde cholangiopancreatography pancreatitisNonsteroidal anti-inflammatory drugsAnti-inflammatory drugsCholangiopancreatography pancreatitisRectal administrationIncidence of PEPRisk of PEPPreventing Post-Endoscopic Retrograde Cholangiopancreatography PancreatitisPancreatic duct injectionOddi dysfunctionSubgroup analysisDuct injectionPatientsTreatment typeRelevant studiesERCPPancreatitisSignificant reductionAdministrationDrugsEfficacySignificant benefitsRiskPlaceboSphincter
2014
Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Njei B, Konjeti VR, Ditah I. Prognosis of Patients With Fibrolamellar Hepatocellular Carcinoma Versus Conventional Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Gastrointestinal Cancer Research : GCR 2014, 7: 49-54. PMID: 24799971, PMCID: PMC4007676.Peer-Reviewed Original ResearchMean overall survivalOverall survivalFL-HCCHepatocellular carcinomaNoncirrhotic patientsSystematic reviewConventional HCCPrognosis of patientsConventional hepatocellular carcinomaFibrolamellar hepatocellular carcinomaRandom-effects modelOutcomes of interestSignificant increaseTypes of HCCLiver transplantationFibrolamellar variantHepatic resectionBetter prognosisClinical courseSurvival outcomesTherapeutic optionsCochrane LibrarySubgroup analysisEgger's testRevMan 5.1